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Background: The present study aimed to explore the impact of dietary docosahexaenoic acid (DHA) on aspects of
the metabolism of Atlantic salmon (Salmo salar). The effects of diets containing increasing levels of DHA (1 g kg−1,
3 g kg−1, 6 g kg−1, 10 g kg−1 and 13 g kg−1) on the liver transcriptome of post-smolt salmon was examined to
elucidate patterns of gene expression and responses of specific metabolic pathways. Total RNA was isolated from the
liver of individual fish and analyzed using a custom gene expression 44K feature Atlantic salmon oligo-microarray.
Results: The expression of up to 911 unique annotated genes was significantly affected by dietary DHA inclusion
relative to a low DHA reference diet. Analysis of a total of 797 unique genes were found with a significant linear
correlation between expression level and dietary DHA. Gene-Set Enrichment Analysis (GSEA) identified a range of
pathways that were significantly affected by dietary DHA content.
Conclusions: Pathways that showed a significant response to dietary DHA level included those for long-chain
polyunsaturated fatty acid biosynthesis, fatty acid elongation, steroid biosynthesis, glycan biosynthesis, protein export
and protein processing in the endoplasmic reticulum. These findings suggest that in addition to clear roles in
influencing lipid metabolic pathways, DHA might also have key functional roles in other pathways distinct from lipid
metabolism.
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Most aquatic species have some requirement for essen-
tial fatty acids (EFA) as dietary nutrients (reviewed by
Glencross [1]). However, the specific class of fatty acids
(n-3 or n-6, long-chain (>C20 or C18), their concentra-
tions, and interactions within the diet, appear to vary
among species. It is generally considered that marine
species have a higher or more defined requirement for
the long-chain polyunsaturated fatty acids (LC-PUFA),
such as docosahexaenoic acid (DHA; 22:6n-3) or eicosa-
pentaenoic acid (EPA, 20:5n-3), while diadromous spe-
cies have a reduced requirement and some freshwater
species appear to have no requirement at all [2–4]).* Correspondence: brett.glencross@gmail.com
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salmonids are amongst the earliest performed in fish
species. The first comprehensive series of studies on
EFA requirements of a salmonid were those of Castell
et al. [5] with rainbow trout (Oncorhynchus mykiss).
These authors identified a dietary requirement of trout
for α-linolenic acid (LNA, 18:3n-3), however it has since
become recognised that the value of LNA as an EFA for
trout and Atlantic salmon exists only because these spe-
cies have the ability to desaturate and elongate LNA to
more biologically active fatty acids such as EPA and
DHA [3, 6, 7]. Further studies have also shown that both
EPA and DHA exert distinct effects on metabolism of
these species, but that DHA appears more biologically
active as an EFA [8–10].
Based on recent work with post-smolt Atlantic salmon
(Salmo salar) examining the response to varying levelsticle is distributed under the terms of the Creative Commons Attribution 4.0
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identified [10] ). Post-smolt Atlantic salmon were used
as they are the first stage of the marine life-phase of this
species, a stage which is the largest user of feed and EFA
in commercial aquaculture. However, a range of other
biochemical and metabolic effects of dietary DHA were
also noted [9] ). While it was evident from the previous
study that the pathways of fatty acid elongation and de-
saturation involved in the biosynthesis of LC-PUFA
themselves were affected at a transcriptional level by
dietary DHA inclusion level, other studies examining the
effects of nutritional variables on broader physiological
and molecular responses in fish have shown that there
are often a suite of metabolic pathways affected by diet
compositions [11–15]. These accessory pathways are
also important, possibly key, and provide a broader per-
spective on the extent that nutritional variables can have
on biological functions and those loci at which they act
[16]. While at a phenomic level a simple growth bioassay
remains arguably the most appropriate and practical way
to examine the effects of many nutritional variables, the
use of molecular and genomic tools is becoming increas-
ingly important in detecting physiological and biochem-
ical mechanisms not otherwise evident at macroscopic
level [17]. Of the expanding genomic technologies avail-
able, microarray provides established methodology proven
to provide broad utility in examining effects beyond the
primary focus [13, 18].
In the present study we aimed to determine the impact
of dietary DHA on the metabolism of Atlantic salmon
by determining the effects on gene expression in the
liver, given that this organ is the primary one involved in
LC-PUFA synthesis [3]. To this end, we investigated the
response of the hepatic transcriptome of post-smolts fed
graded levels of DHA as part of a recently published
growth trial [10]. We hypothesized that, in addition to
the expected responses of specific genes in the LC-
PUFA biosynthesis pathways (e.g. FADS2, ELOVL5) that
were described recently [9], dietary DHA would also im-
pact other genes and metabolic pathways key to the
metabolic response to this important nutrient and thus
further elucidate critical functional roles. The combin-
ation of a series of graded levels of dietary DHA and the
use of a well-established, customized, 44K microarray
would facilitate the identification of genes and pathways
influenced by varying DHA level. Thus, the study de-
sign enabled us to use a regression analysis approach
of DHA dose against expression of each gene that
would enable identification of responses otherwise in-
sensitive to normal pair-wise molecular comparisons,
but potentially highly biologically relevant. Coupling
these analytical tools to the expression of both spe-
cific genes and the cumulative effect of these genes
on pathways, we aimed to elucidate effects of dietaryDHA content on fish physiology and, in doing so,
provide further insight into the functional roles of
this important EFA in fish.
Methods
Background experiment
A single basal diet, similar to commercial diets, but mar-
ginally lower in lipid to force the composition of the lipid
as a point of sensitivity, was formulated and prepared to
provide 460 g kg−1 protein and 200 g kg−1 of lipid at a
gross energy level of 22.0 MJ kg−1 (estimated digestible
protein (DP) and energy (DE) of 440 g kg−1 and 19.5 MJ
kg−1, respectively, with a DP:DE of 22.5 g/MJ). Of the
200 g kg−1 of lipid in the diets 185 g kg−1 was vacuum
infused post-extrusion and it was at this point that the
various dietary treatments were produced by using differ-
ent oil blends. Details on the production of the extruded
pellet diets are given in Glencross et al. [10]. Essentially,
a series of five dietary DHA inclusion levels were created
by blending a range of oils, including an algal derived
(Crypthecodinium sp.) DHA oil source (DHASCO) com-
bined with the use of butter fat and olive oil. The detailed
diet formulations and compositional analysis are pro-
vided in Table 1.
Twenty Atlantic salmon post-smolts of initial weight
110.9 ± 2.61 g (mean ± S.D.) were allocated to each of 15 ×
500 L tanks. The experiment was conducted using a
flow-through seawater system at ambient temperatures
(14.0 ± 0.82 °C; mean ± S.D.) and dissolved oxygen con-
tent (7.8 ± 0.60 mg L−1; mean ± S.D.) for a duration of
62-days. Three replicates (tanks) were used for each
treatment. A summary of the fish performance data ob-
tained from the growth experiment is presented in
Table 2. During the feeding trial an outbreak of amoebic
gill disease occurred and the fish were effectively treated
by freshwater bathing. There were no treatment biases in
the incidence of the disease or its presence at the end of
the study [10]. At the end of the feeding trial, all fish
within each tank were anesthetized using benzocaine.
After each fish was individually weighed, four fish from
each tank were euthanized and the apical tip of each liver
collected and placed within a 1.5 mL Cryotube™ (n = 12
per dietary treatment) and immediately frozen in liquid
N2 before being stored at -80 °C prior to analysis.
Transcriptomic analysis
Transcriptomic analysis was conducted using a custom-
designed 4 × 44K Atlantic salmon oligo microarray
(Agilent Technologies, Wokingham, UK; ArrayExpress
accession no. A-MEXP-2065). The salmon microarray
and laboratory procedures utilized in this study have
been widely used and validated in many previous studies
(e.g. Martinez-Rubio et al. [15, 19]; Morais et al. [20, 21];
Tacchi et al. [22]; Bicskei et al. [23]). Briefly, total RNA
Table 1 Formulations and compositions of the experimental diets
(all values are g kg−1). Derived from Glencross et al. (2014) [10]
D1 D5 D10 D15 D20
Raw materials used
Defatted fishmeal 300.0 300.0 300.0 300.0 300.0
Soy protein isolate 221.0 221.0 221.0 221.0 221.0
Wheat flour 155.0 155.0 155.0 155.0 155.0
Pregelled starch 60.0 60.0 60.0 60.0 60.0
Wheat gluten 60.0 60.0 60.0 60.0 60.0
CaPO4 5.0 5.0 5.0 5.0 5.0
Vitamin/Minerals 5.0 5.0 5.0 5.0 5.0
DL-Methionine 4.0 4.0 4.0 4.0 4.0
L-Histidine 1.5 1.5 1.5 1.5 1.5
L-Lysine 1.5 1.5 1.5 1.5 1.5
Yttrium oxide 1.0 1.0 1.0 1.0 1.0
L-Threonine 1.0 1.0 1.0 1.0 1.0
Olive oil 92.5 88.3 82.0 77.8 71.5
Butter fat 92.5 88.3 82.0 77.8 71.5
DHASCO 0.0 8.4 21.0 29.4 42.0
Composition as measured
(g kg−1)
Dry matter 958 967 952 961 943
Protein 525 526 511 513 521
Fat 181 176 204 205 204
Carbohydrate 212 226 217 213 204
Ash 82 72 68 69 71
Gross Energy 22.3 22.4 23.1 22.7 22.1
Protein:Energy (g MJ−1) 23.5 23.5 22.1 22.6 23.6
Total Saturates 56 51 62 65 67
Total Monounsaturates 86 81 89 86 80
Total PUFA 10 12 12 10 10
Total LC-PUFA 2 5 10 14 17
Total n-3 2 6 9 12 15
Total n-6 9 12 13 12 12
DHA 1 3 6 10 13
Table 2 Growth parameters and feed utilisation. Shown are the reg
D1 D5 D10
Initial weight (g/fish) 110.8 112.5 110.7
Final weight (g/fish) 226.8 226.7 233.1
Weight gain (g/fish) 116.0 114.2 122.5
Gain rate d0-d62 (g/d) 1.87 1.84 1.98
Gain rate d42-d62 (g/d) 2.30 2.66 2.80
Feed intake (g/fish) 106.3 105.9 108.5
Feed Conversion (feed : gain) 0.95 0.96 0.90
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according to manufacturer instructions (Sigma-Aldrich,
Dorset, UK), including a high salt precipitation as recom-
mended for polysaccharide-rich tissues such as liver [24].
RNA quantity, integrity and purity were assessed by agar-
ose gel electrophoresis and spectrophotometry (Nano-
Drop ND-1000, Thermo Scientific, Wilmington, USA).
Equal amounts of RNA from two individual fish livers
from the same tank were pooled together and analyzed
as a single biological replicate, providing two replicates
per tank and six replicates per dietary treatment. The
resulting RNA samples were amplified using TargetAmp™
1-Round Aminoallyl-aRNA Amplification Kit, (Epicentre
Technologies Corporation, Madison, Wisconsin, USA)
following recommended procedures and purified with a
RNeasy Mini Kit (Qiagen, Manchester, UK). Aminoallyl-
amplified RNA (aRNA) samples were labelled with Cy3
dye (GE HealthCare Life Sciences, Buckinghamshire, UK)
while a pool of all aRNA samples was labelled with Cy5
dye (GE HealthCare Life Sciences) and used as a com-
mon reference. Unincorporated dye was removed by puri-
fying the labeled aRNA samples with Illustra AutoSeq G-
50 dye terminator columns (GE HealthCare Life Sciences).
Successful dye incorporation and sample integrity was
assessed for 1 μL aliquots of labeled samples by agarose
gel electrophoresis followed by fluorescent detection of
aRNA products (Typhoon scanner, GE Healthcare Life
Sciences). Cy dye concentration and aRNA quantification
was measured by Nanodrop mediated spectrophometry.
Labelled aRNA samples were hybridized to the custom-
designed array. A dual-label common reference design
was adopted where equal amounts (825 ng) of each indi-
vidual aRNA sample and the common reference pool were
competitively hybridized to one array. Samples were proc-
essed with the Gene Expression Hybridization Kit (Agilent
Technologies), applied to the arrays and immediately in-
cubated using SureHyb hybridization chambers in a DNA
Microarray Hybridization Oven (Agilent Technologies)
at 65 °C for 17 h. Throughout the experiment, sample
processing and hybridization was structured to avoid sam-
ples from the same treatment being overrepresented in a
particular batch in order to prevent unintentional biases.ression statistics. Derived from Glencross et al. (2014) [10]
D15 D20 R2 F-value P-value
113.7 109.2 0.004 0.058 0.813
232.1 231.4 0.106 1.54 0.236
118.5 122.1 0.112 1.64 0.222
1.91 1.97 0.112 1.64 0.222
2.70 2.90 0.250 4.34 0.058
105.3 107.3 0.054 0.747 0.403
0.90 0.90 0.224 3.762 0.074
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ner (Molecular Devices (UK) Lid. Wokingham, UK) and
the resulting images analyzed with Agilent Feature
Extraction Software v.9.5 (Agilent Technologies) to ex-
tract the intensity values and identify the features. The
foreground intensity was computed as the mean value
of pixels, considered a better estimator as being less
susceptible to distortion from outlier values [25], while
background intensities were computed as the median
value of pixels.
Data pre-processing and differentially expressed genes
discovery
Transcriptomic data analysis was performed using R
v.3.0.1 and Bioconductor v.2.13 [26, 27]. Quality control,
data pre-processing and identification of differentially
expressed features/genes were conducted using the
package Limma [28]. Features considered outliers in
more than 30 % of the replicates within at least one
treatment were excluded from further analyses. Fore-
ground intensities were background-corrected using the
normexp approach (maximum likelihood variant “mle”,
offset = 50) as previously reported as the most reliable
method for two-colour microarrays where background
estimates are available (Ritchie et al. [29]; Silver et al.
[30]). Data were log-transformed and normalized using
the function normalizeWithinArrays (method = “loess”).
A second normalization was performed using the nor-
malizeBetweenArrays function (method = “RQuantile”)
[31]. Filtering of control and features expressed just
above background were also removed.
Features of the array were annotated using BLAST
2.2.29+ (blastx) against the entire non-redundant protein
database as well as using the KEGG Automatic Annota-
tion Server to obtain functional annotations [32]. A total
of 92.8 % of all probes were returned with a BLAST an-
notation with e-value < 10 (89.6 % with e-value < 0.001),
while 59 % of probes were returned with a functional an-
notation using the KAAS server. Differentially expressed
features between treatments were estimated by least
squares fitting of linear models on a probe-by-probe
basis using the entire pre-processed dataset. The func-
tion lmFit was used to compute differential expression
and statistics were extracted using ebayes (trend = TRUE)
both functions of the package limma [28]. Contrasts with
p < 0.05 were considered significant (with no multiple
correction adjustment). Genes showing correlation be-
tween expression levels and dietary DHA content
were identified by linear regression fit using limma
with a cutoff of p = 0.05. Features representing the
same target gene as implied from KEGG annotation
were merged into a unique value obtained by select-
ing the feature with the highest F-value. This allowed
a new dataset to be produced where each gene wasonly represented by one feature in order to avoid
redundancy. Merging features resulted in a dataset of
6434 annotated features targeting unique genes.
Gene-Set Enrichment Analysis (GSEA)
Unique annotated sequences were analyzed using the
function gage of the package GAGE (Generally Applic-
able Gene-set Enrichment [33]) to identify mechanistic
changes as suggested by coordinated expression changes
in gene-sets. Only pathways where genes were perturbed
in the same direction (same.dir = T) are reported in this
study in order to define the trend of direction change of
the underlying genes, however two-direction pathways
(same.dir = F) were also analyzed to confirm the pres-
ence of other potentially important trends. Differentially
expressed gene-sets were determined by pairwise com-
parison using D1 as a reference treatment. Gene-sets
with q-values < 0.1 were considered significant, where
the q-value represented the p-value adjusted for false
discovery rate.
Results and discussion
The present study, following on from the phenomic data
presented in Glencross et al. [10] ), showed that the
incremental inclusion of DHA in the diet of post-smolt
Atlantic salmon caused a range of responses in the
hepatic transcriptome. These responses were separated
into different pathways/biochemical processes to aid in-
terpretation and discussion of their potential functional
effects and biological relevance.
Transcriptomic analysis overview
Overall, analyses revealed that RNA extracted from the
liver of fish across the treatment series (D5, D10, D15 and
D20) showed between 773, 631, 911 and 786 genes re-
spectively that were differentially expressed (DE) relative
to that of the reference treatment (D1) when examined on
a pair-wise basis. This differential expression varied sub-
ject to treatment comparison, but in each case this was
around 10 – 14 % of the total genes available on the
microarray for analysis. There were an increasing number
of DE genes from livers of fish fed the higher levels of
DHA relative to treatment D1. A total of 797 unique and
annotated genes were identified using a linear regression
model applied to the DE log fold-change data against
DHA concentration, showing a significant fit to the model
(p < 0.05). Of these, 454 (57 %) were down regulated and
343 (43 %) were upregulated with increasing DHA dose
relative to the D1 reference treatment.
Gene-set enrichment analyses
The GSEA showed significant enrichment in a range of
pathways related to unsaturated (LC-PUFA) fatty acid
biosynthesis (ko01040), fatty acid elongation (ko00062),
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(ko00510 and ko00513), terpenoid backbone biosyn-
thesis (ko00900), proteasome (ko03050), protein export
(ko03060) and protein processing (ko04141) (Fig. 1).
Pathways with significant q-values were all notable in
that there was a consistent down regulation of most
genes in each pathway and the coordinated expression
changes in each gene-set were also all cumulatively
negatively regulated by dietary DHA. The number of
significant treatment contrasts in each of the path-
ways mentioned ranged from one to all four possible
contrasts.
Of those pair-wise contrasts between treatment D1
and each of the other dietary treatments, those that were
consistently significantly different for all four compari-
sons were steroid biosynthesis and N-glycan biosynthesis
(ko00510) pathways. Three of the four pair-wise compar-
isons were significant in the pathways pertaining to
unsaturated (LC-PUFA) fatty acid biosynthesis, fatty acidFig. 1 Mean fold change of genes relative to the D1 reference within the p
significant contrast. Notable is that in each case the mean fold change for
that were significantly different to the D1 reference are indicated (*)elongation, protein export and protein processing in the
endoplasmic reticulum. There were only two compari-
sons significant for both the terpenoid backbone biosyn-
thesis (ko00900) and proteosome (ko03050) pathways.
There was a broader range of pathways that had indi-
cative trends (q-value < 0.3) based on GSEA. When sum-
marised based on pathway classes, it was noted that
pathways in lipid metabolism, the metabolism of terpe-
noids and polyketides, folding, sorting and degradation,
and glycan biosynthesis and metabolism were the most
significant (q-value < 0.1) and these were all under-
expressed relative to dietary treatment D1. However, of
those less significant (0.1 < q < 0.3) notable were the
pathway classes of folding, sorting and degradation
(down-regulated), signalling molecules and interaction
(upregulated), xenobiotics biodegradation and metabol-
ism (upregulated), metabolism of cofactors and vitamins
(upregulated), cell communication (upregulated) and the
immune system (upregulated).athway responses identified using the GSEA that had at least one
each contrast for each pathway was negative. Those contrast q-values
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A series of different approaches to the bioinformatic
analysis of the transcriptomic data were undertaken in
this study. Initially contrasts were made amongst the
treatments for those unique genes within the microarray
with a specific focus on those pathways known to be as-
sociated with DHA influence. Notably these genes were
primarily associated with lipid metabolism including
fatty acid elongation (Fig. 2), fatty acid biosynthesis and
fatty acid degradation (Fig. 3), genes of arachidonic acid
metabolism (Fig. 4) and PPAR signalling pathways
(Fig. 5). Within the 6434 unique annotated sequences
present on the custom array, 197 genes were identified
as being involved in lipid metabolism (KEGG Orthol-
ogy), and subject to the specific diet treatment between
22 and 48 of these genes were significantly DE, relative
to the D1 reference. Of the DE genes, the majority (~70
%) were down regulated relative to the D1 reference.
The proportion of genes significantly down regulated
was higher in fish fed treatments D10 and D15 (i.e. 86
and 77 %, respectively) than that observed in fish fed
treatments D5 and D20 (i.e. 54 and 66 %, respectively).
The use of regression analysis against DHA concentra-
tion identified 28 genes (14 %) within the lipid metabol-
ism subset with a significant fit. Of these relationships,
17 (61 %) were down regulated with increasing DHA
dose and 11 (39 %) were upregulated.
Of the unique annotated sequences, there were five
genes associated with fatty acid biosynthesis, 19 with
fatty acid elongation and 16 with fatty acid degradation.
Key DE genes among the fatty acid biosynthesis andFig. 2 Heat map summary of hepatic expression of fatty acid elongation (k
their expression (log2 fold change) relative to the DHA deficient (D1) treatm
maximal (Max) expression levels, respectively. Expression of each gene was
are ranked by regression P-value, while mean log2 fold change (LogFC) forelongation pathways, that were also significantly respon-
sive to dietary DHA level based on regression analysis,
included ELOVL1 (Elongation of very long chain fatty
acids protein 1, K10247), ELOVL2 (Elongation of very
long chain fatty acids protein 2, K10205) and FADS2
(fatty acid desaturase 2 or delta-6 desaturase, K10226)
(Fig. 2). Each of these genes was significantly down regu-
lated relative to the D1 reference diet. In contrast,
among the fatty acid degradation pathway genes a sig-
nificant relationship was observed between DHA level
and long-chain fatty acid-CoA ligase (K01897) and
glutaryl-CoA dehydrogenase (K00252). In contrast to
the biosynthesis and elongation pathways, substantially
more genes in the fatty acid degradation pathway
were upregulated, albeit none of them dramatically so
(Fig. 3).
The role of DHA and the other LC-PUFA in regulat-
ing lipid metabolism has been the topic of several re-
views [1, 2] ). More recently the focus of this work has
shifted towards studying the effects at a transcriptional
level [9, 17] ). In the present study, the manipulation of
dietary DHA content had limited effect on the primary
fatty acid synthesis pathways as defined by expression of
genes such as acetyl-coenzyme A carboxylase (K11262),
fatty acid synthase (K01071) and malonyl CoA carrier
protein transacylase (K00645), none of which were sig-
nificantly responsive to dietary DHA inclusion level.
The inclusion of DHA did however have a clear effect
on the expression of genes involved in LC-PUFA biosyn-
thesis, as evidenced by the down regulation of ELOVL1,
ELOVL2 and FADS2 in fish fed increasing levels of DHAo00062) genes by fish from each DHA inclusion level treatment and
ent. Red and green shading represents the minimal (Min) and
also analysed by linear regression against DHA inclusion level. Genes
each gene is also shown
Fig. 3 Heat map summary of hepatic expression of fatty acid biosynthesis (ko00061) and degradation (ko00071) genes by fish from each DHA
inclusion level treatment and their expression (log2 fold change) relative to the DHA deficient (D1) treatment. Red and green shading represents
the minimal (Min) and maximal (Max) expression levels, respectively. Expression of each gene was also analysed by linear regression against DHA
inclusion level. Genes are ranked by regression P-value, while mean log2 fold change (LogFC) for each gene is also shown
Fig. 4 Heat map summary of hepatic expression of arachidonic acid metabolism (ko00590) genes by fish from each DHA inclusion level
treatment and their expression (log2 fold change) relative to the DHA deficient (D1) treatment. Red and green shading represents the minimal
(Min) and maximal (Max) expression levels, respectively. Expression of each gene was also analysed by linear regression against DHA inclusion
level. Genes are ranked by regression P-value, while mean log2 fold change (LogFC) for each gene is also shown
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Fig. 5 Heat map summary of hepatic expression of PPAR signalling pathway genes by fish from each DHA inclusion level treatment and their
expression (log2 fold change) relative to the DHA deficient (D1) treatment. Red and green shading represents the minimal (Min) and maximal (Max)
expression levels, respectively. Expression of each gene was also analysed by linear regression against DHA inclusion level. Genes are ranked by
regression P-value, while mean log2 fold change (LogFC) for each gene is also shown
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could also be interpreted as upregulated expression in
fish fed the D1 treatment relative to those fish fed the
higher DHA treatments. This observation was consistent
with that reported by Thomassen et al. [8], who also
identified that DHA inclusion in the diet had an inhibi-
tory effect on both FADS2 and ELOVL2, but that the in-
clusion of dietary EPA did not illicit the same response.
Irrespective, the functional effect in the present study is
similar, fish fed higher levels of DHA expressed lower
levels of these biosynthetic genes suggesting decreased
endogenous synthesis of DHA [6, 7].
Ostbye et al. [34] observed increased expression of the
β-oxidation linked genes acyl-CoA oxidase (K00232) and
carnitine palmitoyltransferase (K08766) with increased
levels of dietary LC-PUFA and, in particular, the addition
of high levels of DHA to the diet of Atlantic salmon.
However, in the present study, direct correlations be-
tween dietary DHA level and the expression of these
genes was weak (P > 0.1) and, even on a pair-wise basis
between D1 and D20, there was only a nominal differ-
ence in expression (K00232: –0.15; K08766: 0.15) sug-
gesting that the direct effects of DHA on β-oxidation in
the present study were limited. However, Ostbye et al.[34] also noted in their study that the dietary levels of
EPA and DHA used were extreme and that this led to
peroxidative damage of the mitochondrial membranes in
their samples. As such, differentiating such peroxidative
effects of high dietary LC-PUFA from functional effects
of DHA becomes more difficult to compare with the
present study where levels of DHA were not so extreme.
It was suggested by Zheng et al. [35] that endogenous
LC-PUFA biosynthesis was regulated by nutritional fac-
tors that modulated primarily the expression of fatty acyl
desaturases, but not the elongases. The present study
provides contrasting evidence to this in that there was
an equally strong transcriptional responses in both
ELOVL and FADS genes to increasing dietary levels of
DHA. Similar observations were reported in the earlier
paper from this study, which measured gene expression
by RTqPCR, where significant pair-wise differences were
observed in a range of LC-PUFA biosynthesis genes
between fish fed the D1 and D20 treatments, with sig-
nificant down regulation of most genes in fish fed the
higher DHA level [9]. Martinez-Rubio et al. [14] also re-
ported that there were statistically significant effects of
varying dietary lipid levels in Atlantic salmon on the
expression of lipid metabolism genes other than those of
Glencross et al. BMC Genomics  (2015) 16:684 Page 9 of 12the fatty acyl desaturases. These authors linked this
effect to the absolute dietary intake of LC-PUFA, noting
that similar such effects were also observed when studies
had varied either the total lipid content of the diet or
had replaced LC-PUFA through the use of dietary lipid
sources other than fish oils [17, 18, 36].
In terms of fatty acid degradation, down regulation of
long-chain-fatty acid-CoA ligase (K01897) with increas-
ing dietary DHA was observed. However, it is of note
that this enzyme plays a role, not just in the fatty acid
degradation (β-oxidation) pathway, but also in that of
fatty acid biosynthesis (ko00061), fatty acid metabolism
(ko1212) and PPAR signalling pathway (ko3320), among
others. The other key observation from this pool of
genes was the relative abundance of genes up-regulated
with increasing dietary DHA in contrast to that observed
in genes from the fatty acid elongation and biosynthesis
pathways. This may reflect decreased expression of β-
oxidative capacity when dietary DHA is in short supply
and the animal is in a sub-optimal nutritional state and
tending to conserve nutrients and energy, resulting in
increased efficiency in the utilization of these nutrients
as was reported in the earlier phenomic study [10].
Expression of genes of arachidonic acid metabolism and
PPAR signalling pathways
Of the unique annotated sequences, there were 21 genes
associated with arachidonic acid metabolism and 26 with
the PPAR signalling pathway. The only DE genes among
the arachidonic acid metabolism pathway, that were also
significantly responsive to dietary DHA level based on
the regression analysis, was prostaglandin F synthase
(K15717) and Prostaglandin E synthase 2-like (K05309),
which were both down-regulated with increasing dietary
DHA, and Cytochrome P450 CYP2X21which was up-
regulated (Fig. 3). Among the PPAR signalling pathway,
there were nine genes that were significantly responsive
to diet DHA level based on the regression analysis
(Fig. 3).
The nutritional regulation of fatty acyl desaturase gene
expression via transcription factors can be influenced
both directly (by LC-PUFA acting as ligands) and indir-
ectly (via autocrine hormones such as eicosanoids acting
as ligands). The role of LC-PUFA in eicosanoid or ara-
chidonic acid (ARA) metabolism in fish has been recog-
nised for some time [37–39]. In the present study, there
was limited impact of variation in dietary DHA levels on
the expression of genes in the ARA metabolism pathway
(ko00590), with the exception of prostaglandin F and E
synthase and a cytochrome P450 (CYP2X21), the first
two of which were down-regulated, and the other up-
regulated with increasing dietary DHA level. Notably,
other key genes in this pathway, such as cyclooxygenase
2 (K11987) and some of the lipoxygenases (K08021,K00460; K00461) were unaffected by dietary DHA. This
suggested that a major mode-of-action of DHA on the
eicosanoid pathway would be down regulation of the
production of prostaglandin F2 series autocrine hormones
with apparently less impact on other enzymes involved in
the production of other eicosanoids, as implicated by the
low response by the majority of genes in the pathways to
dietary DHA level.
It is generally acknowledged that EPA has a role in
acting as a modulator of eicosanoid metabolism by inhi-
biting the conversion of ARA to other eicosanoids inter-
mediaries via the enzyme COX1 and alternatively itself
being converted to eicosanoids with substantially differ-
ent properties to those produced from ARA metabol-
ism/eicosanoid synthesis pathway [3]. Other studies have
also shown a level of suppression of prostaglandin syn-
thesis through the dietary provision of n-3 LC-PUFA
[38] ). In the study by Ghioni et al. [38], the provision of
18:4n-3 and 20:4n-3 to a salmonid cell culture inhibited
the production of prostaglandin F2α (PGF2α) from ARA.
In the present study, the down regulation of prostaglan-
din F synthase (K15717) by increasing dietary DHA was
consistent with inhibited production of prostaglandin F,
albeit this time demonstrated at a gene transcriptional
level. The role of PGF2α in fish is primarily linked to
reproductive development, although it has also been im-
plicated in stimulation of the olfactory responses [40].
The suppression of production of PGF2α through the
inhibiting action of the n-3 LC-PUFA has also been
shown to result in up-regulation of 12-HETE, PGE1 and
PGF1α production in fish [38].
The effects of peroxisomal proliferator-activated recep-
tors (PPARs) have been linked to fatty acyl desaturase activ-
ity, both directly and via a secondary compensatory
response attributed to PPARα influencing β-oxidation and
increasing the overall demand for LC-PUFA [35, 41, 42].
There were few correlations observed between dietary
DHA level and the expression of genes in the PPAR signal-
ling pathway (ko03320). This is consistent with Ostbye
et al. [34], who observed using a RT-qPCR approach an in-
crease in the expression of PPARβ with the addition of high
levels of DHA to the diet of Atlantic salmon, although the
effects observed with increased dietary levels of both DHA
and EPA were not as clear. Examination of the correlation
between expression of ELOVL/FADS genes and PPAR/
FABP genes in the present study also showed a close rela-
tionship (R2 values of 0.477 to 0.971), supporting possible
linkage between PPARs expression and fatty acid desaturase
and elongase expression/activity [42].
In the present study some marginal correlations (q-
value < 0.3) were observed for other genes in signalling
pathways. Notable pathways such as the TNF (ko04668),
NF-kappa B (ko04064), PI3K-Akt (ko04151) and the
mTOR (ko04150) signalling pathways all showed some
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the mean log fold expression was upregulated relative to
the D1 reference diet. Similar transcriptional responses
of specific genes such as the sterol regulatory element
binding protein (SREBP1; k07197) and liver X receptor
(LXR; k08536) to increasing levels of dietary DHA were
reported previously [9]. Interestingly, it was demon-
strated in mice that expression of the Δ5 and Δ6 FADS
were both down regulated with over-expression of the
transcription factors SREBP1 and PPARα [43]. This con-
trasted with the observations in the present study where
both these transcription factors and FADS appeared to
be expressed in parallel.
Expression of steroid biosynthesis pathway genes
One of the main aims of the present study was to use
the large-scale microarray approach to enable the exam-
ination of genes and pathways not normally directly as-
sociated with the manipulation of dietary LC-PUFA
content. Using GSEA we were able to identify a signifi-
cant negative mean fold change of genes in a suite of
pathways, but this was most consistent in the steroid
biosynthesis pathway (ko00100). This pathway is primar-
ily involved in the production of steroid hormone pre-
cursor, cholesterol, and vitamin intermediaries such as
cholecalciferol (vitamin D3).
Previous research has shown that manipulation of
dietary fatty acid content and composition can influence
steroidogenesis in fish [44]. The inhibition of eicosanoid
synthesis via interactions between ARA and EPA has
been shown to have flow-on effects on steroidogenesis
[45]. However, the data presented in the present study
showed that the effect of LC-PUFA on steroidogenesis
extended beyond the role that ARA and EPA play in in-
fluencing eicosanoid metabolism as direct substrates and
the subsequent impacts of those autocrine hormones on
steroidogenesis. Indeed the range of steroids influenced
by these interactions also appeared considerable, with
LC-PUFA implicated in affecting cortisol and progester-
one among others [46–49].
Increased use of vegetable oils in fish diets, resulting in
reduced n-3 LC-PUFA intake, has been reported to alter
the post-stress levels of plasma cortisol [47–49]. It was
shown that dietary fatty acids can influence the expression
of stress response associated genes in some fish species,
such as steroidogenesis acute regulatory protein (StAR)
[49]. The StAR regulatory protein has also been reported to
be influenced by the down regulation of PGF2α production,
which in both the present and previous studies was down
regulated in response to dietary DHA itself. Interestingly
the influence of this regulatory protein has also been re-
ported to impact on steroid levels independent of transcrip-
tional changes and this suggests that a tandem approach of
following both transcription and actual steroid levels wouldperhaps be appropriate [46]. Notably, in addition to
prostaglandin-linked effects, DHA also has the capacity to
modulate steroidogenesis via its influence on PPAR, which
in turn can modulate genes such as StAR [50].
Based on the gene expression data, it will be useful to
measure levels of circulating steroids (e.g. testosterone,
estradiol and cortisone) and steroid precursors (e.g.
pregnenolone, progesterone and corticosterone) in fu-
ture studies as tangible features linking changes in gene
expression to physiological effects. This would allow
further phenomic validation of the transcriptomic re-
sponses observed in the present study.
Expression of N-glycan biosynthesis pathway genes
In the present study, GSEA also identified a significant
impact of DHA in the down-regulation of the N-glycan
biosynthesis pathway. This pathway plays an important
role in synthesis of glycoproteins and proteoglycans, and
these N-linked glycan structures are important in coord-
inating protein-folding during protein synthesis on the
endoplasmic reticulum [51]. Additionally N-linked gly-
cans also play an important role in cell-cell interactions
[51]. The identification of effects of dietary DHA on the
expression of these genes and other signalling genes pro-
vides further support for the complex level of interac-
tions involved in response to n-3 LC-PUFA.
Another form of glycans are the glycosaminoglycans,
which include polymers such as keratin, chondroitin
and dermatan, each of which play roles as structural
carbohydrates in anti-inflammatory responses, coagu-
lation, wound repair and fibrosis in eukaryotic cells
[52, 53]. Therefore, the data also imply that this path-
way, with important pro-inflammatory processes, is
possibly down-regulated by dietary DHA. The identifi-
cation of differential expression of these genes in re-
sponse to DHA provides further evidence of the role of
LC-PUFA on non-lipid metabolism pathways including
inflammatory processes.
Other pathways influenced by dietary DHA level
Other studies examining variation in dietary n-3 LC-
PUFA levels have often reported changes to various im-
munological parameters [54, 55]. In the present study
there were few data to support a systemic impact of
DHA on any of the immune system pathways with weak
q-values identified from the GSEA for most of the anno-
tated genes/pathways. Of those pathways related to the
immune system that were identified it was noted that
there was a general upregulation of immune pathways
relative to D1 with increasing dietary DHA level. This
lends some support to the notion that DHA has effects
(albeit possibly indirect) on the immune system, with
pathways such as the chemokine signalling (ko04062),
FC epsilon RI signalling (ko04664) and Natural Killer
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influenced by dietary DHA and n-3 LC-PUFA in general.
However, the fish were not challenged in this trial and
so it is likely that the extent of the impact of DHA on
immune pathways was not fully apparent.
A range of pathways were also noted that had little to
no activity including amino acid metabolism, cell growth
and death, and the endocrine system among others.
Conclusions
The results of the present study showed that variation in
DHA supply in the diet of post-smolt Atlantic salmon
resulted in significant changes in the expression of a
range of genes, not just those associated with lipid me-
tabolism as might be expected but, indeed, a suite of
‘flow on’ effects in other important pathways. Notably,
there was significant enrichment of transcriptional re-
sponses observed in other biosynthetic pathways such as
steroid (sterol) biosynthesis, glycan biosynthesis, and
protein synthesis, export and processing. The effects on
steroid biosynthetic pathways in particular provided in-
dication of a potential mechanism of action by which
DHA exerts functional effects on a suite of genes
through transcriptional changes. The data suggest it
would be particularly pertinent in future studies examin-
ing the role of DHA (and possibly other LC-PUFA) on
the growth of fish, to focus some attention on the levels
of plasma steroids to observe which of these signalling
molecules is linked to these dietary nutrients, and fur-
ther our understanding of how DHA and other LC-
PUFA elicit their nutritional and physiological impacts.
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